WHO releases its first Essential Diagnostic List
May 16 2018
Following its Advisory meeting in April 2018, the World Health Organisation (WHO) has issued its first listing of Essential Diagnostics. The list is split into general laboratory tests (n= 58) and specific tests for key infections (HIV. TB, hepatitis, syphilis and human papilloma virus) (n=55). It is also split into sections relating to testing in primary care settings versus hospital laboratory settings.
Clinical patterns of mucormycosis in northwest India
May 16 2018
A 5-year survey of clinical patterns of mucormycosis in India reveals that diabetes and intramuscular injections are risk factors for mucormycosis, with presentation often being rhino-orbital-cerebral (45%), cutaneous (30%) or pulmonary (17%). Rapid diagnosis and treatment are essential to reduce mortality rates.
How not to miss a blastomycosis diagnosis in children
May 14 2018
Blastomycosis is a life-threatening disease that presents with mainly nondescript viral symptoms (fever, fatigue, cough, joint pain), but additional signs such as skin lesions and fractures are suggestive of extrapulmonary blastomycosis, particularly in children with a recent history of outdoorsy pursuits or who live near water.
Fluorescent brightener 85 (FB85), a new stain for diagnosing onychomycosis?
May 09 2018
Calcofluor white is used to visualise fungal hyphae under the microscope, but it may not offer a great deal of additional utility over KOH in cases of suspected onychomycosis. Fluorescent brightener 85, a dye used in the wood and textile industries, may be a valuable alternative.
New ESCMID-ECMM-ERS clinical guidelines for aspergillosis released
May 02 2018
New guidelines for aspergillosis have been released by the European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory.